Association of HLA-Bw44 with chlorpromazine-induced autoantibodies.
D000974:Antibodies, Antinuclear / Q000032:analysis; D001323:Autoantibodies / Q000096:biosynthesis*; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D002746:Chlorpromazine / Q000494:pharmacology* / Q000627:therapeutic use; D002908:Chronic Disease; D005802:Genes, MHC Class II; D006680:HLA Antigens / Q000235:genetics*; D015235:HLA-B Antigens; D059948:HLA-B44 Antigen; D006801:Humans; D007075:Immunoglobulin M / Q000096:biosynthesis; D016682:Lupus Coagulation Inhibitor; D008297:Male; D008875:Middle Aged; D012306:Risk; D012559:Schizophrenia / Q000188:drug therapy
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D001779:Blood Coagulation Factors; D006680:HLA Antigens; D015235:HLA-B Antigens; D059948:HLA-B44 Antigen; D007075:Immunoglobulin M; D016682:Lupus Coagulation Inhibitor; D002746:Chlorpromazine